title: Are endothelin-receptor antagonists the preferred treatment for PAH associated with scleroderma?
authors.affiliation: Scleroderma Program at University of Michigan, Ann Arbor, MI 48109-0358, USA. jseibold@umich.edu
authors.forename: James R
authors.initials: JR
authors.lastname: Seibold